Filing Details
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2009-12-18 09:13:06
- Reporting Period:
- 2009-12-17
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 879993 | Dusa Pharmaceuticals Inc | DUSA | () |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1205850 | L Scott Lundahl | C/O Dusa Pharmaceuticals, Inc. 25 Upton Drive Wilmington MA 01887 | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2009-12-17 | 5,322 | $1.31 | 60,729 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
